NeonMind Files New Provisional Patent Application Covering Novel Mechanism of Weight Loss Psychedelics Investing
Nirvana Reports Progress with Health Canada Dealer's License Application and Facility Development Psychedelics Investing
Awakn Life Sciences Receives Regulatory Approval for Flagship Clinic in London to Begin Delivering Treatments Psychedelics Investing
SHAREHOLDER ALERT: Weiss Law Reminds CDR, FHN, SYTE, and GDNSF Shareholders About Its Ongoing Investigations Psychedelics Investing
BetterLife Obtains In Vivo PK Data for BETR-001 Confirming its Bioavailability in Brain Pharmaceutical Investing
Goodness Growth Holdings to Participate in Minnesota Cannabis Symposium for Healthcare Providers Psychedelics Investing
Awakn Life Sciences Appoints Kevin Lorenz as U.S. Head of Commercial Development Psychedelics Investing
Numinus to Participate in Maxim's 2022 Virtual Growth Conference on March 28-30, 2022 Pharmaceutical Investing
